ArticleGland surgery2026
Parathyroid surgery for hypercalcaemic crisis in primary hyperparathyroidism-a retrospective study.
Article in Gland surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypercalcaemic crisis (HCC) is a serious and potentially life-threatening complication of increased serum calcium concentration. It is most commonly due to primary hyperparathyroidism (PHPT), from a parathyroid hormone (PTH) secreting tumour. This paper looks at factors affecting outcomes of parathyroid surgeries in HCC patients. Methods: Data were collected retrospectively including demographics, biochemistry and histology results, details of localisation studies, time from referral to surgery, disease related admissions, length of hospital stay. Statistical analysis was performed between the mild (2.6-2.9 mmol/L), moderate (3-3.5 mmol/L) and severe (>3.5 mmol/L) hypercalcaemia (HC) groups. Operative cure was analysed as a drop of post-operative PTH and normalisation of adjusted calcium after 6 months. Results: A total of 175 patients (132 female, 43 male) were identified to have undergone parathyroid surgeries between 2018 and 2025. Seventy-three percent (n=128) of patients had mild HC, 23% (n=40) had moderate HC and 4% had severe HC (n=7). Preoperative adjusted calcium and preoperative PTH concentrations were statistically significantly higher in the severe HC group (P<0.001). The weight of gland in the severe hypercalcaemic group of patients was statistically significantly higher (P<0.001) with a mean of 10.28 g (range, 0.172-52 g). Nine percent (n=11) of patients with mild, 25% (n=10) with moderate, and 100% of patients (n=7) with severe HC had disease related admission (P<0.001). Conclusions: The statistically significant post-operative drop in PTH and adjusted calcium gave us a success rate of 93% overall, which again is broadly in line with current guidelines and with no statistically significant difference in operative success with the patients presenting level of HC. This study intends to raise awareness for service providers to understand the need to prioritise the surgical treatment of this benign but potentially fatal condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.